diabetes

ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus
Xtalks
Tue, 12/10/19 - 10:35 am
Novo Nordisk
Rybelsus
oral semaglutide
diabetes
ICER
drug pricing
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
Tue, 12/3/19 - 09:50 am
AstraZeneca
diabetes
type 2 diabetes
heart failure
Why Diabetes Stock Insulet Soared 28% in November
Motley Fool
Tue, 12/3/19 - 12:06 am
Insulet
devices
diabetes
Omnipod
insulin pumps
FDA guidance finally opens door for insulin biosimilars
Pharmaforum
Mon, 12/2/19 - 09:54 am
FDA
insulin
biosimilars
diabetes
FDA Updates its Thinking on Immunogenicity Studies for Insulin Biosimilars, Interchangeables
RAPS.org
Tue, 11/26/19 - 09:43 am
FDA
diabetes
insulin
biosimilars
10 New Ways Medtech Could Keep Diabetes in Check
Medical Devices and Diagnostics Industry
Mon, 11/25/19 - 09:42 am
diabetes
devices
Pavmed
diabetic retinopathy
Medios AI
DexCom
Aerami Therapeutics
Brighter
Actise
continuous glucose monitoring
Valeritas
Abbott Labs
Enable Biosciences
Novo Nordisk CEO Jørgensen aims to leverage diabetes know-how, deals into the new decade
Fierce Pharma
Wed, 11/20/19 - 10:45 pm
Novo Nordisk
Lars Fruergaard Jorgensen
Pharma CEOs
diabetes
Lilly putting $400M into U.S. diabetes production, adding 100 jobs
Fierce Pharma
Wed, 11/20/19 - 10:24 am
Eli Lilly
diabetes
drug manufacturing
hirings
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
Mon, 11/18/19 - 10:29 am
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
AHA: AstraZeneca's Farxiga outcomes data looks even better in patients without diabetes
Fierce Pharma
Sat, 11/16/19 - 10:42 pm
AstraZeneca
Farxiga
diabetes
All-in-One Device Reduces the Number of Steps Needed for Diabetes Care
Brighter
Sat, 11/9/19 - 12:15 pm
devices
diabetes
Actiste
blood glucose monitoring
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Tue, 11/5/19 - 10:21 am
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
type 2 diabetes
Why Diabetes Stock Insulet Dropped 12% in October
Motley Fool
Sat, 11/2/19 - 07:46 pm
diabetes
devcies
Insulet
Novo drops oral GLP-1 analog to focus on next-gen Rybelsus
Fierce Biotech
Fri, 11/1/19 - 10:36 am
Novo Nordisk
diabetes
OG2023SC
Rybelsus
oral semaglutide
Sanofi axes cancer combo, early next-gen diabetes drug
Fierce Biotech
Thu, 10/31/19 - 10:09 am
Sanofi
R&D
diabetes
cancer
isatuximab
Libtayo
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
Tue, 10/29/19 - 01:55 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Tue, 10/29/19 - 01:54 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Hancock and Sanofi launches new life insurance product for diabetes
Bizjournals
Mon, 10/28/19 - 11:25 pm
life insurance
insurance
diabetes
Sanofi
Hancock
Lilly USA diabetes chief Enrique Conterno bows out after 27 years
Fierce Pharma
Wed, 10/23/19 - 03:00 pm
Eli Lilly
diabetes
Enrique Conterno
Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law
RAPS.org
Fri, 10/4/19 - 11:24 pm
Nevada
drug pricing
diabetes

Pages